Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AWZ1066S is a highly specific anti-Wolbachia drug candidate for the short-course treatment of filariasis (EC50: 2.5 nM in cell assay).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 16,000 | |||
5 mg | 在庫あり | ¥ 38,500 | |||
10 mg | 在庫あり | ¥ 66,500 | |||
25 mg | 在庫あり | ¥ 111,000 | |||
50 mg | 在庫あり | ¥ 158,500 | |||
100 mg | 在庫あり | ¥ 228,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 42,500 |
説明 | AWZ1066S is a highly specific anti-Wolbachia drug candidate for the short-course treatment of filariasis (EC50: 2.5 nM in cell assay). |
分子量 | 404.39 |
分子式 | C19H19F3N6O |
CAS No. | 2239272-16-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (296.74 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AWZ1066S 2239272-16-1 Microbiology/Virology Parasite oral Inhibitor anti-Wolbachia Onchocerciasis (river blindness) CYP3A4 AWZ-1066S CYP2C9 tropical diseases inhibit lymphatic filariasis (elephantiasis) inhibitor